Business in the Burbs

Acorda sells more shares to stock underwriters

July

Acorda Therapeutics Inc., a biotechnology company in Hawthorne, said the underwriters of its June public stock offering have exercised their entire option to purchase an additional 562,500 shares at $18.50 per share. The exercise of the option increases the size of the total offering to 4,312,500 shares. The company said it plans to use the proceeds for further testing of Fampridine-SR, a drug for people with multiple sclerosis, and other corporate purposes. Acorda shares closed at $19.52, up 24 cents.

This entry was posted on Friday, July 6th, 2007 at 4:27 pm by Julie Moran Alterio.
You can follow any responses to this entry through the RSS 2.0 feed.
Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.